014.JPG
km27.jpg
Snímek obrazovky 2021-05-19 v 17.18.12.
Snímek obrazovky 2021-05-19 v 17.17.24.

Dubsky M, Jirkovska A, Bem R, Fejfarova V, Pagacova L, Sixta B, Varga M, Langkramer S, Sykova E, Jude EB.

Both autologous bone marrow mononuclear cells and peripheral blood progenitor cells therapies similarly improve ischemia in patients with diabetic foot in comparison with control treatment.

Diabetes Metab  Res Rev. 29(5):369-76, 2013.

 

Dubsky M, Jirkovska A, Bem R, Fejfarova V, Varga M, Kolesar L, Pagacova L, Sykova E, Jude EB.

Role of serum levels of angiogenic cytokines in assessment of  angiogenesis after stem cell therapy of diabetic patients with critical limb ischemia.

Cell Transplant. 23(12):1517-23, 2014.

 

Dubský M, Jirkovská A, Bem R, Fejfarová V, Pagacová L, Nemcová A, Sixta B, Chlupac J, Peregrin JH, Syková E, Jude EB.

Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia.

Cytotherapy. 16(12):1733-8, 2014.

 

Havlas V, Kotaška J, Koníček P, Trč T, Konrádová Š, Kočí Z, Syková E.

Use of cultured human autologous bone marrow stem cells in repair of a rotator cuff tear: Preliminary results of a safety study.

Acta Chir. Orthop. Traumatol. Cechoslov. 82:222-227, 2015.

 

Šponer P, Filip S, Kučera T, Brtková J, Urban K, Palička V, Kočí Z, Syka M, Bezrouk A, Syková E.

Utilizing Autologous Multipotent Mesenchymal Stromal Cells and β-Tricalcium Phosphate Scaffold in Human Bone Defects: A Prospective, Controlled Feasibility Trial.

Biomed Res Int. 2016:2076061.

 

Školoudík L, Chrobok V, Kočí Z, Popelář J, Syka J, Laco J, Filipová A, Syková E, Filip S.

The transplantation of hBM-MSCs increases bone neo-formation and preserves hearing function in the treatment of temporal bone defects - on the experience of two month follow up.

Stem Cell Rev. 14(6):860-870, 2018.